CSE bulletin 2023-1008

Effective immediately, Canntab Therapeutics Ltd. has been suspended pursuant to Canadian Securities Exchange Policy 3. The suspension is considered a regulatory halt as defined in National Instrument 23-101 trading rules. A cease trade order has been issued by the Ontario Securities Commission.

For more information about cease trade orders, visit the Canadian Securities Administrators cease trade order database.

Date:  Oct. 5, 2023

Symbol:  PILL